Viva Biotech Honored for AI-Driven Drug Discovery Innovations
Viva Biotech has been awarded the 2025 APAC Technology Innovation Leadership recognition by Frost & Sullivan for its pioneering AI-driven drug discovery platforms. Announced in a press release, the award acknowledges Viva Biotech's efforts in accelerating drug discovery timelines, reducing costs, and expanding therapeutic innovation within the global pharmaceutical R&D ecosystem.
Viva Biotech's AI-Driven Drug Discovery (AIDD) platform, which includes the V-Scepter, V-Orb, and V-Mantle modules, integrates predictive modeling, physics-based simulations, and generative AI with laboratory validation. This approach has enabled the company to support over 150 projects for more than 50 global clients, achieving 30-50% faster discovery and up to 70% cost savings.
The recognition highlights Viva Biotech's leadership in combining AI with laboratory-driven validation to reshape drug discovery, strengthen client partnerships, and deliver scalable innovation. The company's platform supports diverse modalities, including small molecules, antibodies, and emerging therapies, significantly reducing development timelines and costs for global clients.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 2 Avimer Bio and CNIO Detail AI Method for Protein Cage Design Oct 2 SPHERE HEALTH Opens Early Access to AI Hormonal Care Platform Oct 2 SAS and NC State Launch AI Research Partnership Oct 2 MontoHealth Develops AI Agents for Healthcare Administrative Work Oct 1 RFK Jr. says AI can give patients better medical second opinionsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
ACROBiosystems Launches ACRO AIx and Rapid Antibody Validation Service
Enveda Raises $311 Million for AI Drug Discovery
RIVANNA Files 100th Patent for Ultrasound AI
AllyGPO Wins Silver Stevie Award for AllyIQ Platform
Verapath and GenTrust Launch VIRA Wealth Management Platform
Daily AI Brief: the AI news that matters, in your inbox.